Table I.
Demographic, treatment and outcome data for analysed cycles (n = 2128).
| Variable | Mean (SD) | Median | Interquartile range |
|---|---|---|---|
| Age (years) | 33.57 (4.39) | 34 | 31–37 |
| AFC | 13.77 (8.24) | 12 | 8–18 |
| Starting dose (Units) | 250.6 (78.23) | 225 | 200–300 |
| Leading follicle size at pre-trigger scan (mm) | 20.06 (2.28) | 20 | 18–21 |
| Oocyte number | 10.81 (6.78) | 9.5 | 6–15 |
| M2 oocyte number | 8.68 (6.44) | 7 | 4–12 |
| Number fertilised | 6.36 (4.62) | 5 | 3–9 |
|
| |||
| Variable | % of Total | ||
|
| |||
| GnRH antagonist cycles | 88.8 | – | – |
| Folitropin alfa (Gonal F®) used for stimulation) | 81.1 | – | – |
| Menopur® used for stimulation | 18.9 | – | – |
| Live birth rate | 31.53 | – | – |
AFC, antral follicle count; M2, metaphase II.